Evaluation of Educational Feedback in Urology Training: A Survey-Based Assessment of Trainees and Program Directors.

Autor: Waisanen K; Urology, Lee Physician Group Urology, Fort Myers, USA.; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA., Parmar G; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA., Iskhakov N; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA., Baetzhold D; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA., Lutnick E; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA., Henning F; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA., Saade K; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA., Peterson M; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA., Nader N; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA.; VA (Veteran Affairs) WNY (Western New York) Health Care System, Buffalo VA Medical Center, Buffalo, USA., Chevli KK; Urology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA.

Publikováno v: Cureus [Cureus] 2024 Jan 05; Vol. 16 (1), pp. e51716. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).

Effect of pretreatment prostate volume on urinary quality of life following intensity-modulated radiation therapy for localized prostate cancer

Autor: Chevli C, Narayanan R, Rambarran L, Kubicek G, Chevli KK, Duff M

Publikováno v: Research and Reports in Urology, Vol 2013, Iss default, Pp 29-37 (2013)

Connor Chevli,1 Ramkishen Narayanan,1,2 Lisa Rambarran,1 Gregory Kubicek,3 K Kent Chevli,1,2 Michael Duff11Cancer Care of Western New York, Cheektowaga, NY, 2State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo,

Externí odkaz: https://doaj.org/article/f1210c944ce24e8795d6d3be2390311a

Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.

Autor: Chevli KK; State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York., Shore ND; Atlantic Urology Clinics, Carolina Urologic Research Center, Myrtle Beach, South Carolina., Trainer A; Adult Paediatrics Urology & Urogynecology, Omaha, Nebraska., Smith AB; University of North Carolina School of Medicine, Chapel Hill, North Carolina., Saltzstein D; Urology San Antonio, San Antonio, Texas., Ehrlich Y; Rabin Medical Center, Petah-Tikva, Israel., Raman JD; Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania., Friedman B; Lady Davis Carmel Medical Center, Technicon-Israel Institute of Technology, Haifa, Israel., D'Anna R; Arkansas Urology, Little Rock, Arkansas., Morris D; Urology Associates, Nashville, Tennessee., Hu B; Loma Linda University, Loma Linda, California., Tyson M; Mayo Clinic, Scottsdale, Arizona., Sankin A; Albert Einstein College of Medicine, Bronx, New York., Kates M; Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland., Linehan J; John Wayne Cancer Institute, Santa Monica, California., Scherr D; Weill Medical College of Cornell University, New York, New York., Kester S; Urology Center of Florida, Pompano Beach, Florida., Verni M; Urology Center of Las Vegas, Las Vegas, Nevada., Chamie K; UCLA, Los Angeles, California., Karsh L; The Urology Center of Colorado, Denver, Colorado., Cinman A; Tower Urology, Los Angeles, California., Meads A; UroGen Pharma, New York, New York., Lahiri S; UroGen Pharma, New York, New York., Malinowski M; UroGen Pharma, New York, New York., Gabai N; UroGen Pharma, New York, New York., Raju S; UroGen Pharma, New York, New York., Schoenberg M; Albert Einstein College of Medicine, Bronx, New York.; UroGen Pharma, New York, New York., Seltzer E; UroGen Pharma, New York, New York., Huang WC; NYU Langone Urology Associates, New York, New York.

Publikováno v: The Journal of urology [J Urol] 2022 Jan; Vol. 207 (1), pp. 61-69. Date of Electronic Publication: 2021 Aug 26.

New Molecular Markers for Prostate Cancer Diagnosis.

Autor: Amiri, Mahan¹, Samani, Leila Asadi¹, Kashi, Amir Hossein², Khadem, Nazanin³, Mohsen Ziaee, Seyed Amir², Mowla, Seyed Javad¹ sjmowla@modares.ac.ir

Publikováno v: Urology Journal. Jan/Feb2024, Vol. 21 Issue 1, p1-13. 13p.

Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies.

Autor: Luong B; Department of Urology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY., Danforth T; Department of Urology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY., Visnjevac O; Department of Urology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY., Suraf M; Department of Urology, the Western New York Urology Associates, LLC, Cheektowaga, NY., Duff M; Department of Radiation Oncology, the Cancer Care of Western New York, Cheektowaga, NY. Electronic address: mduff@cancercarewny.com., Chevli KK; Department of Urology, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY; Department of Urology, the Western New York Urology Associates, LLC, Cheektowaga, NY.

Publikováno v: Urology [Urology] 2015 Mar; Vol. 85 (3), pp. 511-6. Date of Electronic Publication: 2015 Jan 14.